Together, our in vitro and in vivo results suggest that HIF-1α promotes bone metastases by regulating factors such as CXCR4, which promotes tumor cell homing to bone [50] and VEGF, which promotes angiogenesis. The gene discussed is HIF1A; the disease is neoplasm.